Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chinese Patent Office
Julphar
Cantor Fitzgerald
Merck
US Army

Generated: June 26, 2019

DrugPatentWatch Database Preview

MARQIBO KIT Drug Profile

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which patents cover Marqibo Kit, and when can generic versions of Marqibo Kit launch?

Marqibo Kit is a drug marketed by Acrotech and is included in one NDA. There are three patents protecting this drug.

This drug has forty-six patent family members in sixteen countries.

The generic ingredient in MARQIBO KIT is vincristine sulfate. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vincristine sulfate profile page.

Drug patent expirations by year for MARQIBO KIT
Medical Subject Heading (MeSH) Categories for MARQIBO KIT
Synonyms for MARQIBO KIT
2068-78-2
22-Oxovincaleukoblastine sulfate salt
AI3-52944
AKOS030497863
AS-12168
C46H58N4O14S
CCG-101152
CCRIS 2583
CPD000058540
CS-1778
EINECS 218-190-0
HMS2052D03
HMS2234B06
HY-N0488
Leurocristine sulfate salt
Leurocristine, sulfate (1:1) (salt) (8CI)
Lilly 37231
Marqibo
MCULE-9716648888
MFCD00084729
MLS000069706
MLS000863277
MLS001148250
MLS001401434
MolPort-003-939-860
NC00402
NSC 67574
Oncovin
Onkovin
Opera_ID_836
Q-201925
SAM001246570
SMR000058540
T5IRO3534A
UNII-T5IRO3534A
VCR
VCR sulfate
Vincaleukoblastine, 22-oxo-, sulfate (1:1) (salt)
Vincasar PFS
Vincrex
Vincristine (sulfate)
Vincristine sulfate
Vincristine sulfate (assay), United States Pharmacopeia (USP) Reference Standard
Vincristine sulfate [USAN:USP:JAN]
Vincristine Sulfate Liposomes Injection
Vincristine sulfate salt
Vincristine sulfate salt, 95.0-105.0% (HPLC), powder
Vincristine sulfate, European Pharmacopoeia (EP) Reference Standard
Vincristine sulfate, meets USP testing specifications
Vincristine sulfate, United States Pharmacopeia (USP) Reference Standard
Vincristine sulphate
Vincristinsulfat
Vincristinsulfat [German]
Vincrisul

US Patents and Regulatory Information for MARQIBO KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acrotech MARQIBO KIT vincristine sulfate INJECTABLE, LIPOSOMAL;INTRAVENOUS 202497-001 Aug 9, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Acrotech MARQIBO KIT vincristine sulfate INJECTABLE, LIPOSOMAL;INTRAVENOUS 202497-001 Aug 9, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Acrotech MARQIBO KIT vincristine sulfate INJECTABLE, LIPOSOMAL;INTRAVENOUS 202497-001 Aug 9, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Acrotech MARQIBO KIT vincristine sulfate INJECTABLE, LIPOSOMAL;INTRAVENOUS 202497-001 Aug 9, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for MARQIBO KIT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Acrotech MARQIBO KIT vincristine sulfate INJECTABLE, LIPOSOMAL;INTRAVENOUS 202497-001 Aug 9, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Acrotech MARQIBO KIT vincristine sulfate INJECTABLE, LIPOSOMAL;INTRAVENOUS 202497-001 Aug 9, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Acrotech MARQIBO KIT vincristine sulfate INJECTABLE, LIPOSOMAL;INTRAVENOUS 202497-001 Aug 9, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cipla
AstraZeneca
Chinese Patent Office
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.